福瑞達(600223.SH):頤蓮品牌目前正沿着既定的玻尿酸護膚賽道繼續耕耘
格隆匯8月7日丨福瑞達(600223.SH)近期在接待機構投資者調研時表示,頤蓮品牌目前正沿着既定的玻尿酸護膚賽道繼續耕耘,在堅持噴霧領先地位、打造升級版噴霧的基礎上,新推出了面霜、分體面膜等品類,不斷打造爆款產品,目前產品涵蓋多種功效。渠道方面為線上線下全渠道銷售。
品牌銷售方面,由多場景轉變為空調房護膚場景,圍繞該場景與分眾、小紅書等合作進行系列推廣,擴大噴霧銷量。同時,錨定面霜賽道,通過矩陣式種草推廣,綁定超頭搶佔保濕面霜的消費市場,助力產品銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.